Biotech ETF Overview

With 17 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $18.86B. The average expense ratio is 0.69%. Biotech ETFs can be found in the following asset classes:

  • Equity

The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $9.14B in assets. In the last trailing year, the best performing Biotech ETF was the LABU at 60.75%. The most-recent ETF launched in the Biotech space was the Global X China Biotech Innovation ETF CHB in 09/22/20.

Top ETF Performers

LABU Direxion Daily S&P Biotech Bull 3X Shares 20.20%
BBC Virtus LifeSci Biotech Clinical Trials ETF 7.58%
XBI SPDR S&P Biotech ETF 7.17%
IBBJ Defiance NASDAQ Junior Biotechnology ETF 7.14%
GNOM Global X Genomics & Biotechnology ETF 6.78%

Bottom ETF Performers

LABD Direxion Daily S&P Biotech Bear 3X Shares -23.20%
BIS ProShares UltraShort Nasdaq Biotechnology -4.68%
CHB Global X China Biotech Innovation ETF -1.90%
CHNA Loncar China BioPharma ETF -1.69%
BBH VanEck Vectors Biotech ETF -1.02%

Top Creations

IBB iShares NASDAQ Biotechnology ETF 104.48
XBI SPDR S&P Biotech ETF 27.37
LABD Direxion Daily S&P Biotech Bear 3X Shares 5.36
GNOM Global X Genomics & Biotechnology ETF 3.81
IBBJ Defiance NASDAQ Junior Biotechnology ETF 2.74

Top Redemptions

LABU Direxion Daily S&P Biotech Bull 3X Shares -97.72
FBT First Trust NYSE Arca Biotechnology Index Fund -31.43
BIB ProShares Ultra NASDAQ Biotechnology -8.04
BBH VanEck Vectors Biotech ETF -4.05
GERM ETFMG Treatments Testing and Advancements ETF -2.84

AUM Winners

LABD Direxion Daily S&P Biotech Bear 3X Shares 59.07%
XBI SPDR S&P Biotech ETF 17.49%
GNOM Global X Genomics & Biotechnology ETF 15.48%
BBC Virtus LifeSci Biotech Clinical Trials ETF 7.38%
IBBJ Defiance NASDAQ Junior Biotechnology ETF 7.08%

AUM Losers

BIS ProShares UltraShort Nasdaq Biotechnology -16.56%
LABU Direxion Daily S&P Biotech Bull 3X Shares -13.09%
BIB ProShares Ultra NASDAQ Biotechnology -5.83%
GERM ETFMG Treatments Testing and Advancements ETF -3.42%
BBH VanEck Vectors Biotech ETF -2.69%

ETF Report

Interesting Launches In 2020

Not every viable ETF gathers large amounts of assets right out of the gate.

Features and News

Sleeper Hit ETF Of 2020

Global X's new telemedicine fund proves to be the right ETF for the right moment.

Podcasts

ETF Working Lunch: COVID A New Investment Factor

Joining us is Kristina Hooper, chief global market strategist at Invesco.

Daily ETF Watch

Junior Biotech ETF Debuts

New fund invests in small cap biotechnology stocks. 

ETF Strategist Corner

ETF Open To Close Ratio Jumps

An unusually high number of launches in June boosted the open-to-close ratio. 

Podcasts

ETF Prime Podcast: 2020 Halftime Report

Recapping ETFs at the halfway point of the year.

Features and News

Hot & Cold Health Care ETF Returns

Health care ETFs have diverged sharply as some stocks benefit from the pursuit of virus treatments, others not so much.

ETF.com Analysis

Biotech ETFs: Appraising The Pipelines

Parsing the performance and holdings of different biotech funds.

ETF.com Analysis

Thematic ETFs The New Sectors?

Sometimes an idea just gets you thinking about the possibilities.